Relationship of abdominal obesity with cardiovascular disease, diabetes and hyperlipidaemia in Spain

Objectives  To evaluate the relevance of obesity and abdominal obesity in the prevalence of cardiovascular disease (CVD), diabetes mellitus, hyperlipidaemia and hypertension in primary care patients and to ascertain whether waist circumference (WC) measurement should be included in routine clinical practice in addition to body mass index (BMI).

[1]  A. Pinchera,et al.  3.4 Fat Distribution and Cardiovascular Risk in Obese Women , 2008 .

[2]  J. Després,et al.  International Day for the Evaluation of Abdominal Obesity (IDEA): A Study of Waist Circumference, Cardiovascular Disease, and Diabetes Mellitus in 168 000 Primary Care Patients in 63 Countries , 2007, Circulation.

[3]  B. Popkin,et al.  Adherence to a Mediterranean diet is associated with reduced 3-year incidence of obesity. , 2006, The Journal of nutrition.

[4]  J. Després,et al.  International Day for the Evaluation of Abdominal obesity: rationale and design of a primary care study on the prevalence of abdominal obesity and associated factors in 63 countries , 2006 .

[5]  K. Flegal,et al.  Prevalence of overweight and obesity in the United States, 1999-2004. , 2006, JAMA.

[6]  T. Harris,et al.  Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. , 2006, The New England journal of medicine.

[7]  A. Naska,et al.  Mediterranean diet in relation to body mass index and waist-to-hip ratio: the Greek European Prospective Investigation into Cancer and Nutrition Study. , 2005, The American journal of clinical nutrition.

[8]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[9]  Walter C Willett,et al.  Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. , 2005, The American journal of clinical nutrition.

[10]  Salim Yusuf,et al.  Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. , 2005, American heart journal.

[11]  Andrew R Coggan,et al.  Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. , 2004, The New England journal of medicine.

[12]  A. Jenkins,et al.  Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. , 2004, Diabetes care.

[13]  G. Bray,et al.  Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity. , 2004, Circulation.

[14]  Stephen W. Sorensen,et al.  Lifetime risk for diabetes mellitus in the United States. , 2003, JAMA.

[15]  J. Vioque,et al.  [Prevalence of obesity in Spain: results of the SEEDO 2000 study]. , 2003, Medicina clinica.

[16]  E. Ford,et al.  A comparison of the prevalence of the metabolic syndrome using two proposed definitions. , 2003, Diabetes care.

[17]  J. Buring,et al.  Abdominal and total adiposity and risk of coronary heart disease in men , 2001, International Journal of Obesity.

[18]  D. Williamson,et al.  Report from a Centers for Disease Control and Prevention Workshop on use of adult anthropometry for public health and primary health care. , 2001, The American journal of clinical nutrition.

[19]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[20]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[21]  Who Consultation on Obesity.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation. , 2000, World Health Organization technical report series.

[22]  S. Haffner,et al.  Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. , 1999, Archives of internal medicine.

[23]  T. Møller-Pedersen,et al.  Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2. , 1991, Metabolism: clinical and experimental.

[24]  P. Björntorp,et al.  The Influence of Body Fat Distribution on the Incidence of Diabetes Mellitus: 13.5 Years of Follow-up of the Participants in the Study of Men Born in 1913 , 1985, Diabetes.